TCM
CORZW icon

Triumph Capital Management’s Core Scientific Inc Tranche 1 Warrants CORZW Stock Holding History

Triumph Capital Management’s Portfolio CORZW Stock Details CORZW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9 Hold
1
– – ﹤0.01% 1831
2025
Q4 		$8 Buy
+1
New +$11 ﹤0.01% 1766

Other funds holding CORZW

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $508M AUM 83.62% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Triumph Capital Management's CORZW Position: Q1 2026 in Review

Triumph Capital Management held its Core Scientific Inc Tranche 1 Warrants (CORZW) position steady in Q1 2026 at 1 share worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #1831.

Triumph Capital Management first reported a position in CORZW in Q4 2025 and has held it in 2 quarters since. 63 funds tracked by Wall St. Rank hold CORZW as of Q1 2026.

  • Triumph Capital Management held 1 share of Core Scientific Inc Tranche 1 Warrants worth $9 as of Q1 2026.
  • Triumph Capital Management left its Core Scientific Inc Tranche 1 Warrants share count unchanged in Q1 2026.
  • Core Scientific Inc Tranche 1 Warrants made up ﹤0.01% of Triumph Capital Management's portfolio in Q1 2026, its #1831 holding.
  • Triumph Capital Management first reported a position in Core Scientific Inc Tranche 1 Warrants in Q4 2025 and has held it in 2 quarters since.
  • 63 funds tracked by Wall St. Rank held Core Scientific Inc Tranche 1 Warrants as of Q1 2026.

Based on Triumph Capital Management's 13F filing for Q1 2026, filed 13 May 2026.